TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 131 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,014,000 | -52.6% | 160,908 | -46.4% | 0.14% | -55.4% |
| Q2 2017 | $2,139,000 | -22.4% | 300,000 | 0.0% | 0.31% | -29.7% |
| Q1 2017 | $2,757,000 | +128.0% | 300,000 | 0.0% | 0.44% | +88.4% |
| Q4 2016 | $1,209,000 | -99.9% | 300,000 | 0.0% | 0.23% | +27.5% |
| Q3 2016 | $1,149,000,000 | +88969.8% | 300,000 | 0.0% | 0.18% | -20.5% |
| Q2 2016 | $1,290,000 | -7.1% | 300,000 | 0.0% | 0.23% | -17.0% |
| Q1 2016 | $1,389,000 | -38.5% | 300,000 | +33.3% | 0.28% | -19.1% |
| Q4 2015 | $2,257,000 | +34.4% | 225,000 | 0.0% | 0.34% | +27.2% |
| Q3 2015 | $1,679,000 | -67.0% | 225,000 | +109.5% | 0.27% | -56.2% |
| Q2 2015 | $5,095,000 | +14.0% | 107,400 | -12.0% | 0.61% | -18.8% |
| Q1 2015 | $4,470,000 | – | 122,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |